Polar lipids and Alzheimer’s Disease
/
Blog
Our latest publication on how polar lipids affect the pathology of Alzeimer’s disease: Polar lipids modify Alzheimer’s Disease pathology by reducing astrocyte pro-inflammatory signaling through platelet-activating factor receptor (PTAFR) modulation Figure 1 : A DI TNC1 cells were treated with 1 µM Aβ peptide or 1 µg/µl LPS for 24 h and compared to … Continued